Concentrix (NASDAQ:CNXC) Reaches New 1-Year Low – Should You Sell?

Concentrix Corporation (NASDAQ:CNXC)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as $31.35 and last traded at $30.7160, with a volume of 385314 shares changing hands. The stock had previously closed at $34.76.

Wall Street Analyst Weigh In

CNXC has been the topic of several research analyst reports. Wall Street Zen downgraded shares of Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, January 17th. Weiss Ratings downgraded shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Barrington Research reissued an “outperform” rating and set a $62.00 price objective on shares of Concentrix in a report on Monday, January 12th. Finally, Robert W. Baird set a $52.00 target price on Concentrix in a research note on Wednesday, January 14th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $63.75.

Concentrix Stock Performance

The firm has a fifty day moving average of $40.44 and a 200 day moving average of $44.13. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40. The stock has a market capitalization of $1.86 billion, a price-to-earnings ratio of -1.45, a price-to-earnings-growth ratio of 0.41 and a beta of 0.50.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. The company had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.Concentrix’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $3.26 earnings per share. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. On average, sell-side analysts anticipate that Concentrix Corporation will post 10.11 earnings per share for the current fiscal year.

Concentrix Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were issued a dividend of $0.36 per share. The ex-dividend date of this dividend was Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a yield of 4.8%. Concentrix’s dividend payout ratio is -6.91%.

Insiders Place Their Bets

In other Concentrix news, CEO Christopher A. Caldwell purchased 1,000 shares of the business’s stock in a transaction that occurred on Thursday, January 29th. The stock was purchased at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the purchase, the chief executive officer directly owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 3.20% of the company’s stock.

Institutional Trading of Concentrix

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Huntington National Bank boosted its holdings in Concentrix by 6,011.1% in the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock valued at $25,000 after purchasing an additional 541 shares during the last quarter. Quent Capital LLC purchased a new stake in shares of Concentrix during the 3rd quarter valued at approximately $29,000. Larson Financial Group LLC raised its position in shares of Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares during the period. Geneos Wealth Management Inc. lifted its holdings in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares during the last quarter. Finally, Rothschild Investment LLC grew its position in Concentrix by 14,980.0% in the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after acquiring an additional 749 shares during the period. 90.34% of the stock is owned by institutional investors and hedge funds.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.